Brandywine Global Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.5M | Sell |
|
|||||
|
2025
Q1 | $59.1M | Buy |
|
|||||
|
2024
Q4 | $53.6M | Sell |
|
|||||
|
2024
Q3 | $63.8M | Sell |
|
|||||
|
2024
Q2 | $51.1M | Sell |
|
|||||
|
2024
Q1 | $71.7M | Sell |
|
|||||
|
2023
Q4 | $73.3M | Buy |
|
|||||
|
2023
Q3 | $77.7M | Sell |
|
|||||
|
2023
Q2 | $145M | Sell |
|
|||||
|
2023
Q1 | $169M | Buy |
|
|||||
|
2022
Q4 | $167M | Buy |
|
|||||
|
2022
Q3 | $148M | Sell |
|
|||||
|
2022
Q2 | $173M | Buy |
|
|||||
|
2022
Q1 | $134M | Buy |
|
|||||
|
2021
Q4 | $68.1M | Buy |
|
|||||
|
2021
Q3 | $41.3M | Buy |
|
|||||
|
2021
Q2 | $38.9M | Buy |
|
|||||
|
2021
Q1 | $36.2M | Buy |
|
|||||
|
2020
Q4 | $24.5M | Sell |
|
|||||
|
2020
Q3 | $30.5M | Buy |
|
|||||
|
2020
Q2 | $29.3M | Sell |
|
|||||
|
2020
Q1 | $28.6M | Sell |
|
|||||
|
2019
Q4 | $59.8M | Sell |
|
|||||
|
2019
Q3 | $97.8M | Sell |
|
|||||
|
2019
Q2 | $92.7M | Buy |
|
|||||
|
2019
Q1 | $89.7M | Buy |
|
|||||
|
2018
Q4 | $93.3M | Buy |
|
|||||
|
2018
Q3 | $71.3M | Sell |
|
|||||
|
2018
Q2 | $65.6M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $66.1M | Buy |
|
|||||
|
2017
Q3 | $14.1M | Sell |
|
|||||
|
2017
Q2 | $12.8M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $20K | Sell |
|
|||||
|
2013
Q3 | $53K | Sell |
|
|||||
|
2013
Q2 | $566K | Buy |
|